These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33751730)

  • 1. Monocarbonyl curcuminoids as antituberculosis agents with their moderate in-vitro metabolic stability on human liver microsomes.
    Gagandeep ; Singh M; Kidawi S; Das US; Velpandian T; Singh R; Rawat DS
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-10. PubMed ID: 33751730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB.
    Campaniço A; Carrasco MP; Njoroge M; Seldon R; Chibale K; Perdigão J; Portugal I; Warner DF; Moreira R; Lopes F
    ChemMedChem; 2019 Aug; 14(16):1537-1546. PubMed ID: 31294529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
    Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
    Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
    Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics-Driven Evaluation of the Antioxidant Activity of Curcuminoids and Their Major Reduced Metabolites-A Medicinal Chemistry Approach.
    Girst G; Ötvös SB; Fülöp F; Balogh GT; Hunyadi A
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34200647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylnitro monocarbonyl curcumin analogues: Synthesis and in vitro antitubercular evaluation.
    du Preez C; Legoabe LJ; Jordaan A; Jesumoroti OJ; Warner DF; Beteck RM
    Chem Biol Drug Des; 2023 Mar; 101(3):717-726. PubMed ID: 36350112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.
    Baldwin PR; Reeves AZ; Powell KR; Napier RJ; Swimm AI; Sun A; Giesler K; Bommarius B; Shinnick TM; Snyder JP; Liotta DC; Kalman D
    Eur J Med Chem; 2015 Mar; 92():693-9. PubMed ID: 25618016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel monocarbonyl curcuminoids, evaluation of their efficacy against MRSA, including ex vivo infection model and their mechanistic studies.
    Gagandeep ; Kumar P; Kandi SK; Mukhopadhyay K; Rawat DS
    Eur J Med Chem; 2020 Jun; 195():112276. PubMed ID: 32279050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.
    Zhao W; Wang B; Liu Y; Fu L; Sheng L; Zhao H; Lu Y; Zhang D
    Eur J Med Chem; 2020 Mar; 189():112075. PubMed ID: 31986405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.
    Asfaw H; Laqua K; Walkowska AM; Cunningham F; Martinez-Martinez MS; Cuevas-Zurita JC; Ballell-Pages L; Imming P
    PLoS One; 2017; 12(4):e0176088. PubMed ID: 28423019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis.
    Jang WS; Kim S; Podder B; Jyoti MA; Nam KW; Lee BE; Song HY
    J Microbiol Biotechnol; 2015 Jun; 25(6):946-50. PubMed ID: 25639719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
    Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
    Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of novel diphenyl ether derivatives against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Kar SS; Bhat VG; Shenoy VP; Bairy I; Shenoy GG
    Chem Biol Drug Des; 2019 Jan; 93(1):60-66. PubMed ID: 30118192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.